4 NASH Clinical Trials in Chicago, IL (2026)

Q: How do I join a clinical trial in Chicago?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Chicago research site will contact you.

Recruiting NASH Studies in Chicago

NCT04054310Recruiting

Non-Invasive Quantification of Liver Health in NASH (N-QUAN)

To evaluate, in patients with suspected NASH referred for liver biopsy, the diagnostic performance of CT1 at discriminating those with NAS≥4 \& F≥2 from those without....

Chicago, ILNA225 participantsPerspectum

View Study Details

NCT07491458Recruiting

A Trial to Investigate Safety, Exposure, and Efficacy of HU6 Compared With Placebo in Adult Participants With Metabolic Dysfunction-associated Steatohepatitis (MASH)

Rivus Pharmaceuticals. Inc. is sponsoring this research study to assess the safety and tolerability of HU6 as a possible treatment for patients diagnosed with metabolic dysfunction-associated steatohe...

Chicago, ILPHASE2180 participantsRivus Pharmaceuticals, Inc.

View Study Details

NCT07335601Recruiting

Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH

A Phase 2 double-blind, randomized, placebo-controlled study to evaluate resmetirom in 2 cohorts of subjects with moderate to advanced fibrosis, consistent with stage F2 and F3 fibrosis, who have unde...

Chicago, ILPHASE2120 participantsMadrigal Pharmaceuticals, Inc.

View Study Details

NCT06355310Recruiting

Mechanisms of SGLT2 Inhibition in Pediatric Steatotic Liver Disease

This study is a randomized, double-blind, placebo-controlled trial specifically designed to evaluate the preliminary feasibility, initial efficacy and safety of SGLT2 inhibitors for treating NAFLD in ...

Chicago, ILPHASE240 participantsJustin Ryder

View Study Details

About NASH Clinical Trials in Chicago

Nonalcoholic steatohepatitis (NASH/MASH) is a form of fatty liver disease involving liver inflammation and damage caused by fat buildup, not related to alcohol use. It can progress to fibrosis, cirrhosis, and liver failure. Treatment focuses on weight loss, lifestyle changes, and emerging pharmacological therapies.

There are currently 4 nash clinical trials recruiting participants in Chicago, IL. These studies are seeking a combined 565 participants. Research is being sponsored by Perspectum, Rivus Pharmaceuticals, Inc., Madrigal Pharmaceuticals, Inc. and 1 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

NASH Clinical Trials in Chicago — FAQ

Are there nash clinical trials in Chicago?

Yes, there are 4 nash clinical trials currently recruiting in Chicago, IL. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Chicago?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chicago research site will contact you about next steps.

Are clinical trials in Chicago free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chicago studies also compensate for your time and travel.

What nash treatments are being tested?

The 4 active trials in Chicago are testing new therapies including novel drugs, biologics, and treatment approaches for nash.

Data updated September 5, 2026 from ClinicalTrials.gov